Silexion retires $880K convertible note with $400K cash and 277,777 shares

Silexion Therapeutics Corp

Agreed to retire $880,202.20 outstanding convertible note issued to EarlyBirdCapital; pays $400K cash plus $15K legal fees.
Issues 277,777 ordinary shares to EBC as part of conversion; shares registered under Form S-1.
Any remaining balance after cash and net proceeds from share sales to be settled in further cash payment.
Note originally dated Aug 15, 2024 for $1.25M, due Dec 31, 2025; now fully retired after this agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.